Smith Cathy R bought BSX
May 7, 2026 · Form 4 insider transaction
Smith Cathy R bought 2,209 shares of Boston Scientific Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.; Deferred stock units were granted in lieu of 100% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $125,000 (representing 100% of the amount of the non-employee director compensation program's cash retainer) divided by the closing price of the common stock on the date of grant.